vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and Rithm Property Trust Inc. (RPT). Click either name above to swap in a different company.

Rithm Property Trust Inc. is the larger business by last-quarter revenue ($3.4M vs $2.8M, roughly 1.2× DBV Technologies S.A.). Rithm Property Trust Inc. runs the higher net margin — 95.4% vs -1195.5%, a 1290.9% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs -39.7%). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -43.2%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Rithm Capital Corp. (Rithm) is an American investment management company headquartered in New York that focuses on real estate and alternative investments.

DBVT vs RPT — Head-to-Head

Bigger by revenue
RPT
RPT
1.2× larger
RPT
$3.4M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+198.5% gap
DBVT
158.8%
-39.7%
RPT
Higher net margin
RPT
RPT
1290.9% more per $
RPT
95.4%
-1195.5%
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-43.2%
RPT

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
RPT
RPT
Revenue
$2.8M
$3.4M
Net Profit
$-33.2M
$3.2M
Gross Margin
Operating Margin
-1235.7%
99.6%
Net Margin
-1195.5%
95.4%
Revenue YoY
158.8%
-39.7%
Net Profit YoY
-8.9%
11.2%
EPS (diluted)
$-0.24
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
RPT
RPT
Q4 25
$3.4M
Q3 25
$2.8M
$4.0M
Q2 25
$1.5M
$4.2M
Q1 25
$249.0K
Q2 24
$1.2M
Q1 24
$1.4M
Q4 23
$8.9M
Q3 23
$2.4M
$1.1M
Net Profit
DBVT
DBVT
RPT
RPT
Q4 25
$3.2M
Q3 25
$-33.2M
$-273.0K
Q2 25
$-41.9M
$1.9M
Q1 25
$-3.4M
Q2 24
$-33.1M
Q1 24
$-27.3M
Q4 23
$134.3M
Q3 23
$-16.7M
$-5.5M
Operating Margin
DBVT
DBVT
RPT
RPT
Q4 25
99.6%
Q3 25
-1235.7%
-6.2%
Q2 25
-2806.2%
45.7%
Q1 25
-1416.5%
Q2 24
-2914.9%
Q1 24
-2029.7%
Q4 23
-134.3%
Q3 23
-770.2%
-533.4%
Net Margin
DBVT
DBVT
RPT
RPT
Q4 25
95.4%
Q3 25
-1195.5%
-6.8%
Q2 25
-2858.4%
45.1%
Q1 25
-1363.1%
Q2 24
-2852.4%
Q1 24
-1943.5%
Q4 23
1512.8%
Q3 23
-705.6%
-526.3%
EPS (diluted)
DBVT
DBVT
RPT
RPT
Q4 25
$-0.26
Q3 25
$-0.24
$-0.03
Q2 25
$-0.31
$0.01
Q1 25
$-0.08
Q2 24
$-0.34
Q1 24
$-0.28
Q4 23
$-0.11
Q3 23
$-0.17
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
RPT
RPT
Cash + ST InvestmentsLiquidity on hand
$69.8M
$79.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$52.9M
$291.6M
Total Assets
$110.5M
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
RPT
RPT
Q4 25
$79.3M
Q3 25
$69.8M
$81.4M
Q2 25
$103.2M
$98.6M
Q1 25
$97.4M
Q2 24
$66.2M
Q1 24
$101.5M
Q4 23
$141.4M
Q3 23
$149.1M
$63.9M
Stockholders' Equity
DBVT
DBVT
RPT
RPT
Q4 25
$291.6M
Q3 25
$52.9M
$291.7M
Q2 25
$86.2M
$294.7M
Q1 25
$296.1M
Q2 24
$79.1M
Q1 24
$111.7M
Q4 23
$140.2M
Q3 23
$144.0M
$320.2M
Total Assets
DBVT
DBVT
RPT
RPT
Q4 25
$1.0B
Q3 25
$110.5M
$1.0B
Q2 25
$143.4M
$1.0B
Q1 25
$1.0B
Q2 24
$114.2M
Q1 24
$145.9M
Q4 23
$183.0M
Q3 23
$189.8M
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
RPT
RPT
Operating Cash FlowLast quarter
$-32.4M
$-8.3M
Free Cash FlowOCF − Capex
$-32.6M
FCF MarginFCF / Revenue
-1173.5%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
-2.56×
TTM Free Cash FlowTrailing 4 quarters
$-138.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
RPT
RPT
Q4 25
$-8.3M
Q3 25
$-32.4M
$-5.8M
Q2 25
$-33.9M
$-25.0K
Q1 25
$-1.6M
Q2 24
$-35.1M
Q1 24
$-34.7M
Q4 23
$-13.7M
Q3 23
$-19.6M
$-10.7M
Free Cash Flow
DBVT
DBVT
RPT
RPT
Q4 25
Q3 25
$-32.6M
Q2 25
$-33.9M
Q1 25
Q2 24
$-35.8M
Q1 24
$-36.0M
Q4 23
$-14.0M
Q3 23
$-19.6M
FCF Margin
DBVT
DBVT
RPT
RPT
Q4 25
Q3 25
-1173.5%
Q2 25
-2316.5%
Q1 25
Q2 24
-3084.0%
Q1 24
-2560.6%
Q4 23
-158.2%
Q3 23
-827.3%
Capex Intensity
DBVT
DBVT
RPT
RPT
Q4 25
Q3 25
4.2%
Q2 25
2.2%
Q1 25
Q2 24
63.0%
Q1 24
94.9%
Q4 23
4.0%
Q3 23
2.1%
0.0%
Cash Conversion
DBVT
DBVT
RPT
RPT
Q4 25
-2.56×
Q3 25
Q2 25
-0.01×
Q1 25
Q2 24
Q1 24
Q4 23
-0.10×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons